ADVB
Advanced Biomed Inc. Common Stock
NASDAQ: ADVB · HEALTHCARE · DIAGNOSTICS & RESEARCH
$2.64
-11.41% today
Updated 2026-10-29
Market cap
$6.58M
P/E ratio
—
P/S ratio
51.52x
EPS (TTM)
$-5.00
Dividend yield
—
52W range
$4 – $24
Volume
0.1M
WallStSmart proprietary scores
30
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C7.3
Quality
B+4.0
Profitability
C5.0
Valuation
C+3/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →260 stocks currently score above 75
Price targets
Analyst target
$4.29
+62.50%
12-Month target
$4.29
+62.50%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Profit margin 5,231.00% — above average
+ Debt/equity 0.05x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Negative free cash flow $-583768.00
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | $127637.00 | $127640.00 |
| Net income | $-121521.00 | $-2.78M | $-101524.00 | $6.68M | $-429969.00 |
| EPS | — | — | — | — | $-5.00 |
| Free cash flow | $-3.18M | $-2.20M | $-182449.00 | $-1.95M | $-583768.00 |
| Profit margin | — | — | — | 5,231.30% | 5,231.00% |
Peer comparison
Smart narrative
Advanced Biomed Inc. Common Stock trades at $2.64. Our Smart Value Score of 30/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $127640.00. with profit margins at 5,231.00%.
Frequently asked questions
What is Advanced Biomed Inc. Common Stock's stock price?
Advanced Biomed Inc. Common Stock (ADVB) trades at $2.64, on a P/S of 51.5x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Advanced Biomed Inc. Common Stock overvalued?
Advanced Biomed Inc. Common Stock carries a Smart Value Score of 30/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Advanced Biomed Inc. Common Stock (ADVB)?
The 12-month analyst consensus target is $4.29, about 62.5% above the current $2.64. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Advanced Biomed Inc. Common Stock's revenue?
Advanced Biomed Inc. Common Stock's trailing twelve-month revenue is $127640.00. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio51.52x
ROE-543.36%
Beta—
50D MA$7.49
200D MA$6.10
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—